(ANF) Abercrombie & Fitch - Overview
Sector: Consumer Cyclical | Industry: Apparel Retail | Exchange: NYSE (USA) | Market Cap: 3.436m USD | Total Return: 0.1% in 12m
Avg Turnover: 86.7M
EPS Trend: 79.6%
Qual. Beats: 0
Rev. Trend: 97.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Abercrombie & Fitch Co. (ANF) is a global omnichannel retailer specializing in apparel, accessories, and personal care products for men, women, and children. The company manages a diverse brand portfolio including its namesake Abercrombie & Fitch, Hollister, Gilly Hicks, and Your Personal Best. Operations are distributed across the Americas, EMEA, and Asia-Pacific regions through a mix of physical storefronts, digital platforms, and wholesale partnerships.
As a player in the Apparel Retail sub-industry, the company operates within a highly cyclical sector where profitability is heavily influenced by consumer discretionary spending and seasonal fashion trends. Its business model relies on a multi-brand strategy to segment different price points and demographics, ranging from teen-focused casual wear to premium lifestyle branding. This diversification helps mitigate risks associated with shifting brand loyalties among specific age groups.
Investors can further evaluate the company’s underlying financial health and valuation metrics on ValueRay. Abercrombie & Fitch Co. maintains its corporate headquarters in New Albany, Ohio, and has been in operation since 1892.
- Abercrombie brand revitalization drives significant consolidated revenue growth and margin expansion
- Hollister brand stabilization and inventory management improve overall profitability and cash flow
- Global omnichannel expansion increases digital penetration and reduces physical store overhead
- Elevated freight and raw material costs impact gross margin and operating results
- High sensitivity to discretionary consumer spending patterns affects seasonal sales performance
| Net Income: 506.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -5.30 > 1.0 |
| NWC/Revenue: 10.34% < 20% (prev 11.04%; Δ -0.70% < -1%) |
| CFO/TA 0.17 > 3% & CFO 619.1m > Net Income 506.9m |
| Net Debt (408.6m) to EBITDA (878.2m): 0.47 < 3 |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.8m) vs 12m ago -10.72% < -2% |
| Gross Margin: 61.47% > 18% (prev 0.64%; Δ 6.08k% > 0.5%) |
| Asset Turnover: 153.9% > 50% (prev 150.0%; Δ 3.98% > 0%) |
| Interest Coverage Ratio: 304.5 > 6 (EBITDA TTM 878.2m / Interest Expense TTM 2.38m) |
| A: 0.15 (Total Current Assets 1.65b - Total Current Liabilities 1.11b) / Total Assets 3.54b |
| B: 1.04 (Retained Earnings 3.70b / Total Assets 3.54b) |
| C: 0.21 (EBIT TTM 723.1m / Avg Total Assets 3.42b) |
| D: 1.68 (Book Value of Equity 3.57b / Total Liabilities 2.12b) |
| Altman-Z'' = 7.60 = AAA |
| DSRI: 1.31 (Receivables 146.8m/105.3m, Revenue 5.27b/4.95b) |
| GMI: 1.04 (GM 61.47% / 64.15%) |
| AQI: 0.83 (AQ_t 0.06 / AQ_t-1 0.08) |
| SGI: 1.06 (Revenue 5.27b / 4.95b) |
| TATA: -0.03 (NI 506.9m - CFO 619.1m) / TA 3.54b) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of May 26, 2026, the stock is trading at USD 77.26 with a total of 1,216,800 shares traded.
Over the past week, the price has changed by +9.48%,
over one month by -10.77%,
over three months by -19.45% and
over the past year by +0.14%.
Abercrombie & Fitch has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy ANF.
- StrongBuy: 4
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 114.9 | 48.7% |
P/E Trailing = 7.3126
P/E Forward = 7.2202
P/S = 0.6591
P/B = 2.4621
P/EG = 3.6242
Revenue TTM = 5.27b USD
EBIT TTM = 723.1m USD
EBITDA TTM = 878.2m USD
Long Term Debt = 926.8m USD (estimated: total debt 1.17b - short term 241.3m)
Short Term Debt = 241.3m USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter) (leases 1.17b already included)
Net Debt = 408.6m USD (calculated: Debt 1.17b - CCE 759.5m)
Enterprise Value = 3.84b USD (3.44b + Debt 1.17b - CCE 759.5m)
Interest Coverage Ratio = 304.5 (Ebit TTM 723.1m / Interest Expense TTM 2.38m)
EV/FCF = 10.16x (Enterprise Value 3.84b / FCF TTM 378.4m)
FCF Yield = 9.84% (FCF TTM 378.4m / Enterprise Value 3.84b)
FCF Margin = 7.18% (FCF TTM 378.4m / Revenue TTM 5.27b)
Net Margin = 9.63% (Net Income TTM 506.9m / Revenue TTM 5.27b)
Gross Margin = 61.47% ((Revenue TTM 5.27b - Cost of Revenue TTM 2.03b) / Revenue TTM)
Gross Margin QoQ = 59.49% (prev 62.52%)
Tobins Q-Ratio = 1.09 (Enterprise Value 3.84b / Total Assets 3.54b)
Interest Expense / Debt = 0.20% (Interest Expense 2.38m / Debt 1.17b)
Taxrate = 27.89% (67.6m / 242.4m)
NOPAT = 521.5m (EBIT 723.1m * (1 - 27.89%))
Current Ratio = 1.49 (Total Current Assets 1.65b / Total Current Liabilities 1.11b)
Debt / Equity = 0.83 (Debt 1.17b / totalStockholderEquity, last quarter 1.40b)
Debt / EBITDA = 0.47 (Net Debt 408.6m / EBITDA 878.2m)
Debt / FCF = 1.08 (Net Debt 408.6m / FCF TTM 378.4m)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.82% (Net Income 506.9m / Total Assets 3.54b)
RoE = 38.98% (Net Income TTM 506.9m / Total Stockholder Equity 1.30b)
RoCE = 32.47% (EBIT 723.1m / Capital Employed (Equity 1.30b + L.T.Debt 926.8m))
RoIC = 23.79% (NOPAT 521.5m / Invested Capital 2.19b)
WACC = 8.97% (E(3.44b)/V(4.60b) * Re(11.97%) + D(1.17b)/V(4.60b) * Rd(0.20%) * (1-Tc(0.28)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.78 | Cagr: -5.05%
[DCF] Terminal Value 70.80% ; FCFF base≈438.0m ; Y1≈384.1m ; Y5≈310.3m
[DCF] Fair Price = 91.87 (EV 4.52b - Net Debt 408.6m = Equity 4.11b / Shares 44.7m; r=8.97% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 79.59 | EPS CAGR: 104.2% | SUE: 0.72 | # QB: 0
Revenue Correlation: 97.47 | Revenue CAGR: 13.87% | SUE: 0.10 | # QB: 0
EPS current Quarter (2026-07-31): EPS=2.60 | Chg30d=+4.96% | Revisions=-20% | Analysts=2
EPS current Year (2027-01-31): EPS=10.73 | Chg30d=-0.03% | Revisions=+0% | GrowthEPS=+2.6% | GrowthRev=+3.9%
EPS next Year (2028-01-31): EPS=11.91 | Chg30d=-0.10% | Revisions=-20% | GrowthEPS=+11.0% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: -20%